Drug for Still’s Disease Shows Promise in Phase 2 Trial
Shawna Williams | Mar 1, 2018
Patients with the rare autoimmune condition, highlighted in the Oscar-nominated film The Big Sick, currently have limited treatment options.
Immune Response to Gut Microbes Linked to Diabetes Risk
Immune Response to Gut Microbes Linked to Diabetes Risk
Researchers find that it’s not just high-risk genes, but how children’s bodies respond to their own intestinal microbiota that relates to future diagnoses of type 1 diabetes.
Researchers find that it’s not just high-risk genes, but how children’s bodies respond to their own intestinal microbiota that relates to future diagnoses of type 1 diabetes.
Pinpointing the Culprit
Rachel Berkowitz | Jun 1, 2017
Identifying immune cell subsets with CyTOF
Toward Targeted Therapies for Autoimmune Disorders
Lawrence Steinman | Jun 1, 2016
Training the immune system to cease fire on native tissues could improve outcomes for autoimmune patients, but clinical progress has been slow.
Body, Heal Thyself
Jason Liebowitz | Sep 1, 2015
Reviving a decades-old hypothesis of autoimmunity
$230M for Big Disease
Jef Akst | Feb 5, 2014
The National Institutes of Health is partnering with 10 drug companies to find new treatments for Alzheimer’s disease, diabetes, rheumatoid arthritis, and lupus.
Gut Microbes May Impact Autoimmunity
Abby Olena | Nov 6, 2013
Researchers show that the prevalence of one genus of bacteria correlates with the onset of rheumatoid arthritis.
A Joint Endeavor
Hannah Waters | Jun 14, 2011
Editor's selection in physiology